BLACR
Bellevue Life Sciences Acquisition Corp.
A blank-check company that raised money to acquire a healthcare business, Bellevue Life Sciences was created in 2020 by a team tied to Bellevue Capital Management, a Washington State investment firm — hence its name. In February 2025 it merged with South Korea's OSR Holdings, becoming OSR Health, Inc., which trades on Nasdaq and develops oral cancer vaccines through its Vaximm subsidiary.
RIGHTUnderlying: BLACRCUSIP: 079174124HealthcareUS1 holder
Right entitling holder to receive 1/10th of one share of common stock upon business combination